Blood eosinophils and obstructive lung disease in the general population

S. Wijnant (Ghent, Belgium), L. Lahousse (Ghent, Belgium), M. De Buyzere (Ghent, Belgium), G. Brusselle (Ghent, Belgium), E. Rietzschel (Ghent, Belgium)

Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Wijnant (Ghent, Belgium), L. Lahousse (Ghent, Belgium), M. De Buyzere (Ghent, Belgium), G. Brusselle (Ghent, Belgium), E. Rietzschel (Ghent, Belgium). Blood eosinophils and obstructive lung disease in the general population. 1172

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interpreting blood eosinophil counts in health and obstructive lung disease
Source: Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021
Year: 2022



Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010

Blood cytokine expression in patients with chronic obstructive airway diseases (COAD)
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017

Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005

Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 893-894
Year: 2004


Lymphocyte subpopulations in serum in patients with nonallergic asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 288s
Year: 2006

Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001

Stability of eosinophils in blood in patients with chronic obstructive pulmonary diseasee (COPD) and one hospital admission
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Red blood cell distribution with in patients With chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Blood eosinophils do not reflect lung tissue eosinophils in COPD
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017

Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005


Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006


Cytokine profiles in the lungs of patients with interstitial and obstructive lung diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Blood eosinophilia in chronic obstructive pulmonary disease: impact on exacerbations risk and severity
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002



Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016